Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may help women with low sexual desire after surgical menopause.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Hormonal implants have many side effects that often outweigh their benefits.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Estrogen alone can lower testosterone in some transfeminine people.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.